CompletedNot Applicable

In Vivo Measurement of the Accuracy of the "Neurolocate" Module of the Neurosurgical Robot "Neuromate" in Its Application to Deep Brain Stimulation

France18 participantsStarted 2021-01-26

Plain-language summary

The purpose of this study is to evaluate the accuracy of the Neurolocate recording system of the neurosurgical robot Neuromate, marketed by Renishaw, in order to optimize surgical procedures, costs and patient comfort.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged 18 to 70 years old requiring a stereotactic robot-guided deep brain stimulation procedure * Signature of the Informed Consent Form * Affiliation to the French social security system Exclusion Criteria: * Contraindication to MRI * Hypersensitivity to gadoteric acid, meglumine or any product containing gadolinium. * Anterior and posterior commissure anatomy modifying brain anatomy * Patient unable to complete the Comfort Questionnaire due to cognitive or speech impairment * Pregnant or breastfeeding women

What they're measuring

Euclidean distance between the point theoretically aimed at by the robot and the point actually reached

Timeframe: Day of intervention

Trial details

NCT IDNCT04712552

SponsorCentre Hospitalier Universitaire de Nice

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-01-07

View on ClinicalTrials.gov More Parkinson Disease trials